Trinity Biotech Plc
(NASDAQ) TRIB
Trinity Biotech Plc Financials at a Glance
Market Cap
$13.89M
Revenue (TTM)
$48.65M
Net Income (TTM)
$36.91M
EPS (TTM)
$-2.35
P/E Ratio
-0.32
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.70
Volume
800
Open
$0.70
Price
$0.70
Volume
800
Open
$0.70
Previous Close
$0.70
Daily Range
$0.70 - $0.70
52-Week Range
$0.50 - $3.44
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.70
Volume
800
Open
$0.70
Previous Close
$0.70
Daily Range
$0.70 - $0.70
52-Week Range
$0.50 - $3.44
TRIB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Trinity Biotech Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
401
CEO
John Gillard
Website
www.trinitybiotech.comHeadquarters
Bray, A98 H5C8, IE
TRIB Financials
Key Financial Metrics (TTM)
Gross Margin
35%
Operating Margin
-41%
Net Income Margin
-76%
Return on Equity
0%
Return on Capital
-29%
Return on Assets
-36%
Earnings Yield
-3.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.89M
Shares Outstanding
18.63M
Volume
800
Short Interest
0.00%
Avg. Volume
237.36K
Financials (TTM)
Gross Profit
$21.44M
Operating Income
$21.16M
EBITDA
$16.91M
Operating Cash Flow
$4.19M
Capital Expenditure
$10.06M
Free Cash Flow
$14.26M
Cash & ST Invst.
$5.17M
Total Debt
$100.76M
Trinity Biotech Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$14.25M
-6.0%
Gross Profit
$6.09M
+14.7%
Gross Margin
42.72%
N/A
Market Cap
$13.89M
N/A
Market Cap/Employee
$36.55K
N/A
Employees
380
N/A
Net Income
$5.11M
-7.4%
EBITDA
$115.48K
+89.6%
Quarterly Fundamentals
Net Cash
$115.86M
-27.5%
Accounts Receivable
$15.02M
-29.9%
Inventory
$19.16M
-12.1%
Long Term Debt
$114.86M
+25.7%
Short Term Debt
$2.34M
-0.9%
Return on Assets
-35.59%
N/A
Return on Invested Capital
-28.64%
N/A
Free Cash Flow
$77.11K
+98.8%
Operating Cash Flow
$71.45K
+98.0%